Head & Neck Cancer Diagnostics Market

Head and Neck Cancer Diagnostics Market Size (2023 to 2028)

The global head and neck cancer diagnostics market is predicted to grow at a CAGR of 11.52% during the forecast period. The market has evolved significantly in developed countries. It has enormous prospects in emerging countries such as India, China, Indonesia, and Thailand. In addition, the rising market demand for diagnostic imaging, advances in treatment modes, and incorporation of novel technologies in diagnostic equipment will further propel the market growth during the forecast period.

Head and Neck cancer is among the ten most common types of cancer worldwide, and these forms of cancer are especially prevalent in regions with high alcohol and tobacco intake across the globe. Early detection and prompt treatment offer the best chance of curing these diseases.

MARKET DRIVERS:

The rising number of diagnostic procedures for head and neck cancer, particularly pharyngeal and oral cancers propelling the market growth. Rising disposable income leading to increased human healthcare expenditure, increasing demand for diagnostic imaging, advancements in treatment modes, and incorporation of new technologies in diagnostic equipment will further drive the market growth during the forecast period. Due to the increase in personal healthcare spending in the United States, the health industry in the region is growing rapidly, resulting in the growth of the cancer diagnostics market head and neck.

Personal health spending in the United States has seen a significant increase over the past decade, from $ 2.010 billion in 2010 to $ 3,979 billion in 2020, resulting in an average annual percentage change of 5.2% during this period, according to a report by the CDC. Hospital spending accounted for the largest share, with 42.3% of total personal healthcare spending in the United States in 2020. Next are medical and clinical expenditures, prescription drugs, and dental care, which accounted for a 24.8% share, 13.7%, and 5.6%, respectively. It is estimated that the propensity of the population to spend on this industry in exchange for improved technologies and advanced treatment methods and dental and hospital care will drive the growth of the global market for head and neck cancer diagnostic region by the end of 2025.

Adopting a sedentary lifestyle and changing food habits are significant factors driving market growth. Increasing incidences of chronic diseases such as cancer are also thriving in the growth of the market. Growing concerned about the health and the need for early diagnosis of the issues significantly influence the demand of the market. Head and neck cancer diagnostics are anticipated to have a tremendous growth rate. The increasing need for targeted therapies and growing awareness of the availability of various treatment procedures are leveraging the market's growth. The rising geriatric population across the world is ascribed to outshining the growth rate of the market.

Increasing support from private and public organizations through investments is solely to surge growth opportunities for the market. Increasing the intake of alcohol and tobacco products, especially in well-developed countries, is fuelling the demand of the head and neck cancer diagnostics market. The rise in the need to live a healthy lifestyle by diagnosing diseases early as it has a permanent cure is also ascribed to bolster the market demand extensively. Furthermore, launching innovative imaging techniques in the medical sector is significantly influencing the market's growth.

MARKET RESTRAINTS:

However, the Lack of skilled physicians to analyze the reports accurately is slowly impeding the market demand. The cost of installing the devices is very high, which cannot be affordable by small-scale industries limiting the growth of the market. Frequent changes in software technologies may also hamper the development of the head and neck cancer diagnostics market. Along with this, a rise in the number of risks due to the failure of systems in real-time application limits the growth rate of this market. Also, rapid changes in economic strategies are inhibiting the demand of the market.

Impact of COVID-19 on the global heck and neck cancer diagnostics market:

The World Health Organization (WHO) announced COVID-19 as an emergency public health issue. During the COVID-19 epidemic, head and neck cancer patients' treatment and diagnosis have been greatly affected. The COVID-19 pandemic creates challenges in the management of patients with head and neck cancer. Cancer treatments were canceled or postponed during the lockdown period where emergency care patients got treatment with utmost care. Cancer patients face significant difficulties in disease diagnosis and treatment. During this period, hospitals are high-risk areas for spreading the disease, and cancer patients may easily be exposed to viral infections. Telemedicine may play a vital role in the primary assessment of signs and symptoms for cancer patients. However, the market is expected to fall soon into the normal position and register its regular growth rate by the end of 2021.

REPORT COVERAGE:

This research report on the global head and neck cancer diagnostics market has been segmented and sub-segmented into the following categories:

Head & Neck Cancer Diagnostics Market - By Test Type:

• Diagnostic Imaging              
  • PET/CT
  • MRI
  • X-Ray
  • Barium Swallow Test
• Biopsy       
  • Incisional Biopsy
  • Fine Needle Aspiration Biopsy
  • HPV Testing
• Endoscopy              
  • Pharyngoscopy
  • Laryngoscopy
  • Panendoscopy
• Dental Diagnostics
  • Fluorescence Visualization
  • Toluidine Blue Dye-Based Method
  • Acetic Acid Rinse Method
  • Brush Biopsy

Based on the type, the diagnostic imaging segment had the highest share of the global market in 2022. Growing awareness of the benefits of early diagnosis and the rise in the availability of various treatment procedures majorly boost segmental growth. People demand effective treatment procedures at any cost and ensuring the well-being of a patient after treatment is outshining the market's demand to an extent. Besides, increasing economic strength in well-developed and developing countries is prompting the need for the market. The Head & neck cancer diagnostics market is fueled by growing concern about the patient’s health condition and government plans to decrease the cost of treatment procedures in hospitals.

Head & Neck Cancer Diagnostics Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

Geographically, the global head and neck cancer diagnostics market is expected to increase yearly with an increased incidence of the disease. North America holds the highest share of the market owing to the quick acceptance of advanced technologies in every field. Increasing capital income in both developed and developing countries are escalating the growth of the market in this region. Though this form of cancer is not prevalent in all its forms in the US, it has increased presence and incidence in Asia, Africa, and Europe, making its screening and early detection highly important to affect proper treatment and care. Accurate detection at an early stage can lead to appropriate treatment and a long, healthier life.

Europe is following North America in leading the share of the market with the rise in government initiatives in favor of the ordinary people by launching reimbursement schemes. 

In recent years, Asia Pacific has had the fastest growth rate and is expected to register the highest CAGR during the forecast period. The increasing geriatric population is undoubtedly a primary factor for the market to grow. The growing economy in most countries is gearing up the demand of the market in this region.

Latin America is anticipated to have a slight inclination in the growth rate shortly. The growing prevalence of having an adequate diagnosis to have appropriate treatment procedures for diseases impacts the market's demand for positive.

The Middle East and Africa are projected to have substantial growth opportunities in foreseen years with the increasing scale of healthcare centers with the latest equipment.

KEY MARKET PARTICIPANTS:

Some of the notable companies operating in the global head and neck diagnostics market profiled in this report are Philips Healthcare, Varian Medical Systems, Siemens Healthcare, GE Healthcare, Shimadzu Corporation, Identafi, Velscope VX, and AdDent Inc.